First News

Report Overview [150 Pages Report] The global  respiratory drug delivery market  is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis. Report Segmentation The respiratory drug delivery market by formulation segment is further divided into device type and formulation type. The types of respiratory drug delivery is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The dry powder inhalers segment is expected to witness the highest growth during the forecast period due to the advantages associated with the use of these inhalers, such as short administration & preparation time, ease of use, and fewer irri...

According to a new market research report “ Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) – Forecasts to 2021 ” published by MarketsandMarkets, The market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Browse 104 market data Tables and 33 Figures spread through 150 Pages and in-depth TOC on  “ Pulmonary/ Respiratory Drug Delivery Market “ http://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug-delivery-market-179682410.html Early buyers will receive 10% customization on this report.   Growth in this Pulmonary Drug Delivery Market is mainly driven by increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development...

Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis. The global  respiratory drug delivery market  is projected to reach  USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016 , at a  CAGR of 6.5%  during the forecast period. The respiratory drug delivery market by formulation segment is further divided into device type and formulation type. The types of respiratory drug delivery is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The dry powder inhalers segment is expected to witness the highest growth during the forecast period due to the advantages associated with the use of these inhalers, such as short administration & preparation time, ease of use, and fewer irritant effects. The respiratory drug d...

The market is witnessing growth due to factors such as increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers, and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. The  respiratory drug delivery market  is segmented based on formulations, canister type, applications, end users, and regions. The formulation segment is further divided into device type and formulation type. The respiratory drug delivery market, by device type, is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The metered dose inhalers segment is expected to account for the largest share of the market by type of delivery by device, in 2016. Factors such as the efficient absorption of drugs through the lungs and negligible side effects (as drugs are exposed only to the lungs) are contributing to the growth of this segment. Download PDF -  https://www.marketsan...

According to the new market research report “ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021 ", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. Don’t miss out on business opportunities in  Respiratory Drug Delivery Market . Speak to our analyst and gain crucial industry insights that will help your business grow:  https://www.marketsandmarkets.com/speaktoanalyst.asp?id=179682410 The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhale...

Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis. The global respiratory drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period.  The  respiratory drug delivery market , based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles. Based on applications, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other applications (cardiovascular disease, diabetes, respiratory therap...

According to the new market research report  “Pulmonary/  Respiratory Drug Delivery Market  by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) – Forecasts to 2021″ , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. Don’t miss out on business opportunities in  Pulmonary/ Respiratory Drug Delivery Market.   Speak to our analyst and gain crucial industry insights that will help your business grow:  https://www.marketsandmarkets.com/speaktoanalyst.asp?id=179682410 The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological dev...

The global respiratory drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. The market is witnessing growth due to factors such as increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers, and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. The respiratory drug delivery market is segmented based on formulations, canister type, applications, end users, and regions. The formulation segment is further divided into device type and formulation type. The  respiratory drug delivery market , by device type, is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The metered dose inhalers segment is expected to account for the largest share of the market by type of delivery by device, in 2016. Factors such as the efficient absorption of drugs through the ...